Steve Kozachok

Steve has extensive experience in private equity, IT and healthcare transactions. He practices principally in the areas of:

• Mergers and acquisitions.
• Financings.
• Strategic relationships.
• Commercial contracts.
• Entity formation and business planning.
• Corporate governance.
• General corporate and securities law.

Steve has nearly 25 years of corporate and securities law experience. He practiced as an associate and then partner in the corporate group of a large local law firm for eight years before serving for three years as the associate general counsel for a major medical device company, where he was responsible for M&A, financings, securities law compliance, and reporting and corporate governance matters.

Representative IT-related Transactions Include:

• Financing of Leadferno, LLC
• Sale of Nifty Marketing to ProSites, Inc.
• Sale of GatherUp to Grade Us
• Sale of Spyder Trap to Bright Health.
• Sale of LuciData to The Newberry Group.
• Sale of Network Instruments, LLC to Thoma Bravo, LLC.
• Sale of Secure Computing Corporation to McAfee, Inc.
• Sale by Secure Computing Corporation of SafeWord network access business to Aladdin Knowledge Systems Ltd.
• Acquisition by Secure Computing Corporation of Securify, Inc.

Representative Healthcare-related Transactions Include:

• Representation of StemoniX, Inc. in its merger with publicly-held Cancer Genetics, Inc.
• Representation of Blue Cross and Blue Shield of Minnesota in the $500 million sale of its Further HSA business to HealthEquity.
• Sale of a nonprofit hospital and senior care facility to a large, nonprofit health system.
• Acquisitions by UnitedHealth Group entities of:
• Fidelity Insurance Group. 
• Mid Atlantic Medical Services, Inc.
• Golden Rule Financial Corporation.
• AmeriChoice Corporation.
• Definity Health Corporation.
• Spectera, Inc.
• Lifemark Corporation.
• Acquisitions by St. Jude Medical, Inc. of:
• Advanced Neuromodulation Systems, Inc. 
• EP MedSystems, Inc.
• A contingent acquisition option for an embolic protection device company.
• Sale of Pulmonetic Systems, Inc. to VIASYS Healthcare (now CareFusion).
• Acquisition of a cutting-edge medical technology company by an S&P 500 client.
• Venture investment by a medical device company in an ablation catheter company.
• PIPE investment by St. Jude Medical, Inc. in Cambridge Heart, Inc.
• Acquisition by Quintiles Transnational Corp. of the assets of Bioglan Pharma, Inc.
• Financing transactions for:
• StemoniX, Inc.
• Raymedica, Inc.
• HealthEZ, Inc.
• EM Vascular, Inc.
• Virtuel Medical, Inc.
• Image-Guided Neurologics, Inc.

Representative Private Equity Transactions Include:

• Sale of a manufacturer and value-added distributor of trade show exhibits.
• Sale of a property maintenance services company.
• Purchase and later sale of a shooting target and firearm accessory company.
• Purchase and later sale of a casino chair manufacturing company.
• Purchase of numerous heavy equipment manufacturing companies.
• Purchase of a trucking tarp manufacturing company.
• Purchase and later sale of a wine capsule manufacturing company.
• Purchase of a UK-based arts and crafts company.
• Purchase of a direct mail company.
• Purchase of a taxidermy supply company.
• Purchase of a UK-based cash drawer company.

Representative Emerging Company Clients Include:

• StemoniX, Inc.
• Phenomix Sciences, Inc.
• EmpNia, Inc.
• Ilion Medical, Inc.
• ClickSWITCH, Inc. 
• Crotega, L.L.C.
• Surgical Design Innovations, LLC

• Presenter, "Best Practices for Your M&A Playbook," June 12, 2014